New York, NY -- (SBWIRE) -- 02/19/2013 -- Switzerland-based Roche Holding (OTCQX: RHHBY) continues to be bullish in recent weeks and trades near the 52-week high and all time high of $56.16. Roche is a research focused company biotech company with strength in both pharmaceuticals and diagnostics as well as a world leader in tissue-based Cancer diagnostics.
Several stocks in the cancer diagnostics and immunotherapy sector have been showing bullish momentum in the last weeks and Roche Holding seems to be following the same trend. In the last two years the company’s stock took off from $34 to $56 showing only cyclical pullbacks followed by greater upside.
With the recent highs reached by the company’s stock many investors could be wondering if a pullback could be imminent and how high the stock could go.
Read the trend analysis for RHHBY and what the short-term indicators show for the company’s stock here: http://www.wallstreetscoop.net/market-scan/?symbol=RHHBY
Advaxis (OTCQB: ADXS) started the year on strong volume and positive upwards momentum and gained as much as 400% going from 3 cents in January to 14 cents a month later.
ADXS is another stock that is gaining from the strong investor interest in Cancer focused stocks. The Company has nine distinct cancer-fighting constructs in various stages of development.
The company recently provided investors with an audio interview from Tom Moore, Chairman and CEO. During the interview the CEO discussed the company&aposs business model, immunotherapy pipeline, targeted markets, and recent developments. The interview also includes background information on the management team and near-term goals of the Company.
Find out what the Trend Analysis indicates about ADXS for the short term and how it could affect investors and traders here:
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.
WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetScoop.net
Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetscoop.net/disclaimer/
Wall Street Scoop
For more information on this press release visit: http://www.sbwire.com/press-releases/which-cancer-focused-stocks-are-posting-significant-gains-otcqx-rhhby-otcqb-adxs-209098.htm
Thomas GreeneTelephone: 347-905-5009Email: Click to Email Thomas GreeneWeb: http://www.WallstreetScoop.net